International Journal of Immunopathology and Pharmacology最新文献

筛选
英文 中文
Evaluation of crypt apoptotic bodies and apoptotic indices in pediatric celiac disease by routine staining and H2AX immunostaining. 应用常规染色和H2AX免疫染色评价小儿乳糜泻隐窝凋亡小体及凋亡指标。
IF 3.5 3区 医学
International Journal of Immunopathology and Pharmacology Pub Date : 2021-01-01 DOI: 10.1177/20587384211026791
Sarah Adel Hakim, Dalia Abd El-Kareem
{"title":"Evaluation of crypt apoptotic bodies and apoptotic indices in pediatric celiac disease by routine staining and H2AX immunostaining.","authors":"Sarah Adel Hakim,&nbsp;Dalia Abd El-Kareem","doi":"10.1177/20587384211026791","DOIUrl":"https://doi.org/10.1177/20587384211026791","url":null,"abstract":"<p><p>Celiac disease (CD) is an immune-mediated disorder with premature apoptosis occurring along the entire crypt-villous axis. H2AX is the end product of the intrinsic apoptotic pathway. This is the first study to assess apoptotic body counts (ABC) by H&E and apoptotic indices (AI) by immunohistochemistry (IHC) in pediatric CD. The aim of the current study was to evaluate ABC in pediatric patients with CD prior to and following institution of a gluten free diet (GFD). Sixty-three pediatric endoscopic duodenal samples were assessed and divided into three groups. A total of 21 samples from treatment naïve CD patients, 21 from the same patients after instituting a GFD, and 21 from non-celiac patients as a control group. Histopathological evaluation of ABC by H&E, and immunohistochemistry assessment of apoptotic indices (AI) by H2AX antibody were performed. The mean maximum ABC and AI were significantly higher in treatment naïve CD than in GFD and control samples. These values were also significantly higher in treatment naïve Marsh 3C (flat) than in Marsh 1, 2, 3A, and 3B (non-flat) CD cases. GFD samples with persistent flat lesions had significantly higher ABC and AI than GFD non-flat cases. ROC analysis of the mean maximum ABC and AI of treatment naïve CD cases had a statistically significant predictive potential for persistent villous atrophy at a cut-off level ⩾6.61 (<i>P</i> = 0.008) and ⩾105.4 (<i>P</i> = 0.003), respectively. Histopathological evaluation of crypt apoptotic bodies could provide predictive potential for continued villous atrophy following GFD.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"35 ","pages":"20587384211026791"},"PeriodicalIF":3.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/20587384211026791","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39239263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The COVID-19 vaccination experience in Bangladesh: Findings from a cross-sectional study. 孟加拉国的 COVID-19 疫苗接种经验:横断面研究结果。
IF 3.5 3区 医学
International Journal of Immunopathology and Pharmacology Pub Date : 2021-01-01 DOI: 10.1177/20587384211065628
Md Rabiul Islam, Moynul Hasan, Waheeda Nasreen, Md Ismail Tushar, Mohiuddin Ahmed Bhuiyan
{"title":"The COVID-19 vaccination experience in Bangladesh: Findings from a cross-sectional study.","authors":"Md Rabiul Islam, Moynul Hasan, Waheeda Nasreen, Md Ismail Tushar, Mohiuddin Ahmed Bhuiyan","doi":"10.1177/20587384211065628","DOIUrl":"10.1177/20587384211065628","url":null,"abstract":"<p><strong>Objectives: </strong>Vaccination rollout against COVID-19 has started in developed countries in early December 2020. Mass immunization for poor or low-income countries is quite challenging before 2023. Being a lower-middle-income country, Bangladesh has begun a nationwide COVID-19 vaccination drive in early February 2021. Here, we aimed to assess the opinions, experiences, and adverse events of the COVID-19 vaccination in Bangladesh.</p><p><strong>Methods: </strong>We conducted this online cross-sectional study from 10 February 2021, to 10 March 2021, in Bangladesh. A self-reported semi-structured survey questionnaire was used using Google forms. We recorded demographics, disease history, medication records, opinions and experiences of vaccination, and associated adverse events symptoms.</p><p><strong>Results: </strong>We observed leading comorbid diseases were hypertension (25.9%), diabetes (21.1%), heart diseases (9.3%), and asthma (8.7%). The most frequently reported adverse events were injection site pain (34.3%), fever (32.6%), headache (20.2%), fatigue (16.6%), and cold feeling (15.4%). The chances of having adverse events were significantly higher in males than females (<i>p</i> = 0.039). However, 36.4% of respondents reported no adverse events. Adverse events usually appeared after 12 h and went way within 48 h of vaccination. Besides, 85.5% were happy with the overall vaccination management, while 88.0% of the respondents recommended the COVID-19 vaccine for others for early immunization.</p><p><strong>Conclusion: </strong>According to the present findings, reported adverse events after the doses of Covishield in Bangladesh were non-serious and temporary. In Bangladesh, the early vaccination against COVID-19 was possible due to its prudent vaccine deal, previous mass vaccination experience, and vaccine diplomacy.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"35 ","pages":"20587384211065628"},"PeriodicalIF":3.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4e/17/10.1177_20587384211065628.PMC8689597.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39817338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A scoping review of the pathophysiology of COVID-19. COVID-19 病理生理学范围综述。
IF 3 3区 医学
International Journal of Immunopathology and Pharmacology Pub Date : 2021-01-01 DOI: 10.1177/20587384211048026
Paul E Marik, Jose Iglesias, Joseph Varon, Pierre Kory
{"title":"A scoping review of the pathophysiology of COVID-19.","authors":"Paul E Marik, Jose Iglesias, Joseph Varon, Pierre Kory","doi":"10.1177/20587384211048026","DOIUrl":"10.1177/20587384211048026","url":null,"abstract":"<p><p>COVID-19 is a highly heterogeneous and complex medical disorder; indeed, severe COVID-19 is probably amongst the most complex of medical conditions known to medical science. While enormous strides have been made in understanding the molecular pathways involved in patients infected with coronaviruses an overarching and comprehensive understanding of the pathogenesis of COVID-19 is lacking. Such an understanding is essential in the formulation of effective prophylactic and treatment strategies. Based on clinical, proteomic, and genomic studies as well as autopsy data severe COVID-19 disease can be considered to be the connection of three basic pathologic processes, namely a pulmonary macrophage activation syndrome with uncontrolled inflammation, a complement-mediated endothelialitis together with a procoagulant state with a thrombotic microangiopathy. In addition, platelet activation with the release of serotonin and the activation and degranulation of mast cells contributes to the hyper-inflammatory state. Auto-antibodies have been demonstrated in a large number of hospitalized patients which adds to the end-organ damage and pro-thrombotic state. This paper provides a clinical overview of the major pathogenetic mechanism leading to severe COVID-19 disease.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"35 ","pages":"20587384211048026"},"PeriodicalIF":3.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cc/ef/10.1177_20587384211048026.PMC8477699.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39453906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vancomycin and daptomycin modulate the innate immune response in a murine model of LPS-induced sepsis. 万古霉素和达托霉素在lps诱导的脓毒症小鼠模型中调节先天免疫反应。
IF 3.5 3区 医学
International Journal of Immunopathology and Pharmacology Pub Date : 2021-01-01 DOI: 10.1177/20587384211031373
Stefan Muenster, Valentina Zschernack, Birte Dierig, Stilla Frede, Georg Baumgarten, Mark Coburn, Christian Putensen, Christina Katharina Weisheit
{"title":"Vancomycin and daptomycin modulate the innate immune response in a murine model of LPS-induced sepsis.","authors":"Stefan Muenster,&nbsp;Valentina Zschernack,&nbsp;Birte Dierig,&nbsp;Stilla Frede,&nbsp;Georg Baumgarten,&nbsp;Mark Coburn,&nbsp;Christian Putensen,&nbsp;Christina Katharina Weisheit","doi":"10.1177/20587384211031373","DOIUrl":"https://doi.org/10.1177/20587384211031373","url":null,"abstract":"<p><p>Sepsis is a leading cause of death worldwide, despite the use of multimodal therapies. Common antibiotic regimens are being affected by a rising number of multidrug-resistant pathogens, and new therapeutic approaches are therefore needed. Antibiotics have immunomodulatory properties which appear to be beneficial in the treatment of sepsis. We hypothesized that the last-resort antibiotics vancomycin (VAN) and daptomycin (DMC) modulate cell migration, phagocytosis, and protein cytokine levels in a murine model of lipopolysaccharide (LPS)-induced sepsis. Ten to twelve-week-old C57BL/6 mice (<i>n</i> = 4-6 animals per group) were stimulated with LPS for 20 h, followed by the administration of VAN or DMC. The outcome parameters were leukocyte accumulation and effector function. Quantification of the immune cells in the peritoneal lavage was performed using flow cytometry analysis. Phagocytosis was measured using pHrodo <i>E. coli</i> BioParticles. The response of the cytokines TNFα, IL-6, and IL-10 was measured in vitro using murine peritoneal macrophages stimulated with LPS and VAN or DMC. VAN decreased both the peritoneal macrophage and the dendritic cell populations following LPS stimulation. DMC reduced the dendritic cell population in the peritoneal cavity in LPS-infected mice. Both antibiotics increased the phagocytic activity in peritoneal macrophages, but this effect was diminished in response to LPS. Phagocytosis of dendritic cells was increased in LPS-infected animals treated with VAN. VAN and DMC differently modulated the levels of pro-and anti-inflammatory cytokines. In a murine model of LPS-induced sepsis, VAN and DMC exhibit immunomodulatory effects on cells involved in innate immunity. The question of whether these antibiotics exhibit synergistic effects in the treatment of septic patients, beyond their bactericidal properties, should be further evaluated in future studies.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"35 ","pages":"20587384211031373"},"PeriodicalIF":3.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/20587384211031373","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39211646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Expression of cPLA2γ mRNA and protein differs the response of PBMC from severe and non-severe asthmatics to bacterial lipopolysaccharide and house dust mite allergen. cPLA2γ mRNA和蛋白的表达不同于重症和非重症哮喘患者PBMC对细菌脂多糖和屋尘螨变应原的反应。
IF 3.5 3区 医学
International Journal of Immunopathology and Pharmacology Pub Date : 2021-01-01 DOI: 10.1177/2058738421990952
Ewa Pniewska-Dawidczyk, Izabela Kupryś-Lipińska, Gabriela Turek, Dorota Kacprzak, Joanna Wieczfinska, Paulina Kleniewska, Piotr Kuna, Rafal Pawliczak
{"title":"Expression of cPLA<sub>2</sub>γ mRNA and protein differs the response of PBMC from severe and non-severe asthmatics to bacterial lipopolysaccharide and house dust mite allergen.","authors":"Ewa Pniewska-Dawidczyk,&nbsp;Izabela Kupryś-Lipińska,&nbsp;Gabriela Turek,&nbsp;Dorota Kacprzak,&nbsp;Joanna Wieczfinska,&nbsp;Paulina Kleniewska,&nbsp;Piotr Kuna,&nbsp;Rafal Pawliczak","doi":"10.1177/2058738421990952","DOIUrl":"https://doi.org/10.1177/2058738421990952","url":null,"abstract":"<p><p>Chronic inflammation in asthmatics is initiated/exacerbated by many environmental factors, such as bacterial lipopolysaccharide and allergens. Phospholipase A<sub>2</sub> and histone acetyltransferase/deacetylases are enzymes involved in inflammatory process, particularly in lipid inflammatory mediators production and control of transcription of many inflammatory genes, respectively. The aim of the study was to identify differences in the inflammatory process in patients with severe and non-severe asthma, taking as a criterion expression of two groups of enzymes: phospholipases A<sub>2</sub> and histone acetyltransferases/deacetylases. Thirty-two patients with severe, non-severe atopic to house dust mite asthmatics and 14 healthy volunteers were recruited. Peripheral blood mononuclear cells were stimulated with <i>Dermatophagoides pteronyssinus</i> allergen (nDer p1) and bacterial lipopolysaccharide (LPS). The expression of phospholipases A<sub>2</sub> and histone acetyltransferases and deacetylases were assessed using TaqMan Low Density Array Cards. The protein expression was analyzed with immunoblot. Increased expression of phospholipase A2 Group IVC (<i>PLA2G4C)</i> and cytosolic phospholipase A2 gamma (cPLA<sub>2</sub>γ) protein was observed in peripheral blood mononuclear cells (PBMC) from severe asthmatics in response to LPS and nDer p1, compared to non-severe asthmatics. nDer p1-stimulated PBMC from severe asthmatics exhibit induced expression of <i>HDAC1</i> and similar trend was observed in protein concentration. Decreased expression of <i>EP300</i> occurred in PBMC of severe asthmatics. PBMC from non-severe asthmatics showed decreased expression of <i>HDAC2</i> and <i>PLA2G15</i> after LPS treatment. In conclusion, in response to LPS and dust mite allergen, PBMC from severe and non-severe asthmatics modulate expression of selected phospholipase A<sub>2</sub>, histone acetyltransferases and deacetylases, while increased expression of cPLA<sub>2</sub>γ characterizes PBMC response from severe asthmatics.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"35 ","pages":"2058738421990952"},"PeriodicalIF":3.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2058738421990952","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25401350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Expression of proteins associated with airway fibrosis differs between children with allergic asthma and allergic rhinitis. 过敏性哮喘和变应性鼻炎患儿气道纤维化相关蛋白的表达不同。
IF 3.5 3区 医学
International Journal of Immunopathology and Pharmacology Pub Date : 2021-01-01 DOI: 10.1177/2058738421990493
Paulina Sobkowiak, Beata Narożna, Irena Wojsyk-Banaszak, Anna Bręborowicz, Aleksandra Szczepankiewicz
{"title":"Expression of proteins associated with airway fibrosis differs between children with allergic asthma and allergic rhinitis.","authors":"Paulina Sobkowiak,&nbsp;Beata Narożna,&nbsp;Irena Wojsyk-Banaszak,&nbsp;Anna Bręborowicz,&nbsp;Aleksandra Szczepankiewicz","doi":"10.1177/2058738421990493","DOIUrl":"https://doi.org/10.1177/2058738421990493","url":null,"abstract":"<p><p>Allergic rhinitis (AR) and allergic asthma (AA) exhibit similar inflammatory response in the airways. However, the remodelling is more extensive in the lower airways, suggesting that the inflammation itself is not sufficient for allergic phenotype. We aimed to analyse whether the expression of selected 27 inflammatory and fibrosis-related proteins may be altered in AR and AA in the paediatric population and whether the expression pattern is either similar (due to the inflammation) or disease-specific (due to the remodelling). We analysed 80 paediatric subjects: 39 with AA, 21 with AR and 20 healthy children. The diagnosis of AR and AA was based on clinical manifestation, lung function, positive skin prick tests and increased immunoglobulin E levels. Serum levels of selected inflammatory proteins were measured with custom Magnetic Luminex Assay. Statistical analysis was performed in Statistica v.13. CCL2/MCP1, GM-CSF, gp130 and periostin concentrations were significantly lower, whereas IL-5 levels were higher in AA compared to the control group. CD-40L, CHI3L1/YKL-40, EGF, GM-CSF and periostin levels were significantly decreased in patients with AR than in the control group. Comparison of AA and AR patients revealed significant changes in CHI3L1/YKL-40 (<i>P</i> = 0.021), IL-5 (<i>P</i> = 0.036), periostin (<i>P</i> = 0.013) and VEGFα (<i>P</i> = 0.046). Significantly altered proteins were good predictors to distinguish between AA and AR (<i>P</i> < 0.001, OR 46.00, accuracy 88.57%). Our results suggest that the expression of four fibrotic proteins was significantly altered between AA and AR, suggesting possible differences in airway remodelling between upper and lower airways.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"35 ","pages":"2058738421990493"},"PeriodicalIF":3.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2058738421990493","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25401355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
EXPRESSION OF CONCERN: 'Green tea polyphenols protect PC12 cells against H2O2-induced damages by upregulating lncRNA MALAT1'. 关注表达:“绿茶多酚通过上调lncRNA MALAT1来保护PC12细胞免受h2o2诱导的损伤。”
IF 3.5 3区 医学
International Journal of Immunopathology and Pharmacology Pub Date : 2021-01-01 DOI: 10.1177/20587384211000802
{"title":"EXPRESSION OF CONCERN: 'Green tea polyphenols protect PC12 cells against H2O2-induced damages by upregulating lncRNA MALAT1'.","authors":"","doi":"10.1177/20587384211000802","DOIUrl":"https://doi.org/10.1177/20587384211000802","url":null,"abstract":"","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"35 ","pages":"20587384211000802"},"PeriodicalIF":3.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/20587384211000802","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25406238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immuno-modulation by heat-killed Lacticaseibacillus paracasei MCC1849 and its application to food products. 热杀副干酪乳杆菌MCC1849的免疫调节及其在食品中的应用
IF 3.5 3区 医学
International Journal of Immunopathology and Pharmacology Pub Date : 2021-01-01 DOI: 10.1177/20587384211008291
Hazuki Maehata, Satoshi Arai, Noriyuki Iwabuchi, Fumiaki Abe
{"title":"Immuno-modulation by heat-killed <i>Lacticaseibacillus paracasei</i> MCC1849 and its application to food products.","authors":"Hazuki Maehata,&nbsp;Satoshi Arai,&nbsp;Noriyuki Iwabuchi,&nbsp;Fumiaki Abe","doi":"10.1177/20587384211008291","DOIUrl":"https://doi.org/10.1177/20587384211008291","url":null,"abstract":"<p><p>Probiotics are microorganisms that confer health benefits to host. Well-known examples include <i>Bifidobacterium</i> and <i>Lactobacillus</i> species. In recent years, interest in promoting our health with probiotics has grown as life expectancy and health awareness has increased. However, some concerns for safety and stability exist for these live organisms. Thus, \"postbiotics\" and \"paraprobiotics,\" non-viable heat-killed microbial cells or cell fractions that retain health benefits, are increasingly favored. Unfortunately, little information on clinical efficacy and mechanisms of action is available compared with many available probiotics. <i>Lacticaseibacillus</i> (previous name <i>Lactobacillus</i>) <i>paracasei</i> MCC1849 is a commonly used lactic acid bacterial strain in Japan that displays immuno-modulatory effects in humans in non-viable heat-killed form. This review discusses health benefits of heat-killed <i>L. paracasei</i> MCC1849 immune modulation and offers a theoretical basis for its mechanisms of action. We also discuss the feasibility of using heat-killed probiotics for application in food products.</p>","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"35 ","pages":"20587384211008291"},"PeriodicalIF":3.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/20587384211008291","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25533235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
RETRACTION NOTICE: Total glucosides of paeony suppresses experimental autoimmune uveitis in association with inhibition of Th1 and Th2 cell function in mice. 撤回注意:芍药总苷抑制实验性自身免疫性葡萄膜炎与抑制小鼠Th1和Th2细胞功能有关。
IF 3.5 3区 医学
International Journal of Immunopathology and Pharmacology Pub Date : 2021-01-01 DOI: 10.1177/20587384211040389
{"title":"RETRACTION NOTICE: Total glucosides of paeony suppresses experimental autoimmune uveitis in association with inhibition of Th1 and Th2 cell function in mice.","authors":"","doi":"10.1177/20587384211040389","DOIUrl":"https://doi.org/10.1177/20587384211040389","url":null,"abstract":"","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"35 ","pages":"20587384211040389"},"PeriodicalIF":3.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/eb/94/10.1177_20587384211040389.PMC8419561.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39376767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RETRACTION NOTICE: Notoginsenoside R1 protects human keratinocytes HaCaT from LPS-induced inflammatory injury by downregulation of Myd88. 撤销声明:三七皂苷R1通过下调Myd88来保护人角质形成细胞HaCaT免受lps诱导的炎症损伤。
IF 3.5 3区 医学
International Journal of Immunopathology and Pharmacology Pub Date : 2021-01-01 DOI: 10.1177/20587384211040398
{"title":"RETRACTION NOTICE: Notoginsenoside R1 protects human keratinocytes HaCaT from LPS-induced inflammatory injury by downregulation of Myd88.","authors":"","doi":"10.1177/20587384211040398","DOIUrl":"https://doi.org/10.1177/20587384211040398","url":null,"abstract":"","PeriodicalId":14046,"journal":{"name":"International Journal of Immunopathology and Pharmacology","volume":"35 ","pages":"20587384211040398"},"PeriodicalIF":3.5,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/10/5c/10.1177_20587384211040398.PMC8419531.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39376771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信